Start Date: February 2011
End Date: July 2015
This is a 4-year Integrated Project co-funded under the European Community’s 7th Framework Programme aiming at developing new tools, IT infrastructure and VPH models to accelerate personalized medicine for the benefit of the patient.
In p-medicine Biovista, together with 18 partners from 9 European countries and Japan have dedicated themselves to create support and sustain new knowledge and innovative technologies to overcome current problems in clinical research and pave the way for a more individualized therapy.
Information arising from post-genomic research and combined genetic and clinical trials on the one hand, and advances from high-performance computing and informatics on the other hand, are rapidly providing the medical and scientific community with an enormous opportunity to improve prognosis of patients with cancer by individualizing treatment and moving forward to personalized medicine. Multi-level data collection within clinico-genomic trials and interdisciplinary analysis by clinicians, molecular biologists and other specialists involved in life science is mandatory to further improve the outcome of cancer patients’ treatment. It is essential to merge the research results of biomolecular findings, imaging studies, scientific literature and clinical data from patients and to enable users to easily join, analyze and share even great amounts of data.The different partners with academic, industrial and clinical background are joining their forces to create an infrastructure that will facilitate the translation from current practice to personalized medicine.